The looming antibiotic crisis has prompted the development of new strategies towards fighting infection. Traditional antibiotics target bacterial processes essential for viability, whereas proposed antivirulence approaches rely on the inhibition of factors that are required only for the initiation and propagation of infection within a host. Although antivirulence compounds have yet to prove their efficacy in the clinic, bacterial signal peptidase I (SPase) represents an attractive target in that SPase inhibitors exhibit broad-spectrum antibiotic activity, but even at sub-MIC doses also impair the secretion of essential virulence factors. The potential consequences of SPase inhibition on bacterial virulence have not been thoroughly examined, and are explored within this review. In addition, we review growing evidence that SPase has relevant biological functions outside of mediating secretion, and discuss how the inhibition of these functions may be clinically significant.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279723 | PMC |
http://dx.doi.org/10.1016/j.bmc.2016.09.048 | DOI Listing |
Cells
December 2024
Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka 422-8529, Japan.
Eur J Med Chem
February 2025
MOE Joint International Research Laboratory of Animal Health and Food Safety, Risk Assessment Center of Veterinary Drug Residue and Antimicrobial Resistance, Center for Veterinary Drug Research and Evaluation, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China; Sanya Institute of Nanjing Agricultural University, Nanjing Agricultural University, Sanya, 572025, China. Electronic address:
Increasing antimicrobial resistance underscores the urgent need for new antibiotics with unique mechanisms. Type I signal peptidase (SPase I) is crucial for bacterial survival and a promising target for antibiotics. Herein we designed and synthesized innovative tetrahydroacridine-9-carboxylic acid derivatives by optimizing the initial hit compound SP11 based on virtual screening.
View Article and Find Full Text PDFDalton Trans
January 2025
Department of Chemistry, School of Natural Sciences, Shiv Nadar Institution of Eminence, Delhi-NCR, NH91, Tehsil Dadri, Greater Noida, Uttar Pradesh 201314, India.
Arylomycin, a potent antibiotic targeting bacterial signal peptidase, is difficult to synthesize experimentally due to its poor to moderate yields and the formation of a mixture of compounds. A recent experimental bioengineering work shows that the core of arylomycin can be efficiently synthesized by engineering the cytochrome P450 enzyme from sp.; however, the mechanism of the same was not elucidated.
View Article and Find Full Text PDFbioRxiv
November 2024
Department of Biological Sciences, Virginia Tech, Blacksburg, VA 24061, USA.
is a Gram-positive anaerobic spore-forming bacterial pathogen of humans and animals. also produces type IV pili (T4P) and has two complete sets of T4P-associated genes, one of which has been shown to produce surface pili needed for cell adherence. One hypothesis about the role of the other set of T4P genes is that they could comprise a system analogous to the type II secretion systems (TTSS) found in Gram-negative bacteria, which is used to export folded proteins from the periplasm through the outer membrane to the extracellular environment.
View Article and Find Full Text PDFJ Cell Biol
December 2024
School of Biological Sciences and Institute of Biodiversity, Seoul National University, Seoul, South Korea.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!